[go: up one dir, main page]

PA8486601A1 - Formulaciones antiparasitos - Google Patents

Formulaciones antiparasitos

Info

Publication number
PA8486601A1
PA8486601A1 PA19998486601A PA8486601A PA8486601A1 PA 8486601 A1 PA8486601 A1 PA 8486601A1 PA 19998486601 A PA19998486601 A PA 19998486601A PA 8486601 A PA8486601 A PA 8486601A PA 8486601 A1 PA8486601 A1 PA 8486601A1
Authority
PA
Panama
Prior art keywords
antiparasite
formulations
doramectin
injection
action
Prior art date
Application number
PA19998486601A
Other languages
English (en)
Inventor
Valerie Denise Harding
Stephen Richard Wicks
Timothy Michael Lukask
Snezana Milojevic
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8486601A1 publication Critical patent/PA8486601A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE DESCRIBE EN LA PRESENTE FORMULACIONES ANTIPARÁSITOS DE ACCIÓN DE DORAMECTINA, ADECUADAS PARA INYECCIÓN
PA19998486601A 1998-12-16 1999-12-07 Formulaciones antiparasitos PA8486601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827727.0A GB9827727D0 (en) 1998-12-16 1998-12-16 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
PA8486601A1 true PA8486601A1 (es) 2000-09-29

Family

ID=10844352

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998486601A PA8486601A1 (es) 1998-12-16 1999-12-07 Formulaciones antiparasitos

Country Status (21)

Country Link
US (1) US6699847B2 (es)
EP (1) EP1140068B1 (es)
JP (1) JP3848537B2 (es)
AP (1) AP9901699A0 (es)
AR (1) AR019499A1 (es)
AT (1) ATE269074T1 (es)
AU (1) AU762892B2 (es)
BR (1) BR9916265A (es)
CA (1) CA2355102C (es)
DE (1) DE69918165T2 (es)
DK (1) DK1140068T3 (es)
ES (1) ES2221455T3 (es)
GB (1) GB9827727D0 (es)
GT (1) GT199900213A (es)
MA (1) MA26710A1 (es)
PA (1) PA8486601A1 (es)
PE (1) PE20001244A1 (es)
PT (1) PT1140068E (es)
TN (1) TNSN99225A1 (es)
TW (1) TW524691B (es)
WO (1) WO2000035445A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003257778A1 (en) * 2002-08-02 2004-02-23 Shenzhen Salubris Pharmaceuticals Co., Ltd. A riboflavin derivative and its manufacture and uses
AU2003235019A1 (en) * 2003-08-17 2005-03-03 Sirene Call Pty Ltd Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle
AU2009271299B2 (en) * 2008-06-24 2014-09-11 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
ES2399228T3 (es) 2009-02-16 2013-03-26 Ah Usa 42 Llc Formulación de doramectina a dosis elevada
CN103417477B (zh) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的多拉菌素o/w型注射液及其制备方法
EP2916702B1 (en) 2012-11-09 2019-09-18 Aktiebolaget Electrolux Blender
EA037747B1 (ru) * 2019-04-01 2021-05-18 Севиндж Аллахверди кызы АЛИЕВА Антипаразитарное средство

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL151903B (nl) 1965-03-24 1977-01-17 Schering Ag Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat.
DE3377064D1 (en) 1982-12-28 1988-07-21 Bayer Ag Stable aminoglycoside-penicillin injection formulation
EP0140255B1 (en) 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
IL79765A (en) 1985-08-23 1992-02-16 Lilly Co Eli Injectable sustained release formulations of bovine somatotropin
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
DE69229318T2 (de) 1991-09-30 1999-11-18 Merck & Co Inc Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
DE4410970C1 (de) 1994-03-29 1995-07-20 Talbot Waggonfab Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung
US5580574A (en) 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US6013636A (en) * 1995-09-25 2000-01-11 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil

Also Published As

Publication number Publication date
DE69918165T2 (de) 2004-10-14
CA2355102A1 (en) 2000-06-22
AP9901699A0 (en) 2001-05-22
ES2221455T3 (es) 2004-12-16
JP2002532422A (ja) 2002-10-02
TW524691B (en) 2003-03-21
BR9916265A (pt) 2001-11-20
PT1140068E (pt) 2004-09-30
ATE269074T1 (de) 2004-07-15
DK1140068T3 (da) 2004-07-12
EP1140068B1 (en) 2004-06-16
GB9827727D0 (en) 1999-02-10
US20020142972A1 (en) 2002-10-03
EP1140068A1 (en) 2001-10-10
AU762892B2 (en) 2003-07-10
GT199900213A (es) 2001-06-07
MA26710A1 (fr) 2004-12-20
DE69918165D1 (de) 2004-07-22
WO2000035445A1 (en) 2000-06-22
JP3848537B2 (ja) 2006-11-22
TNSN99225A1 (fr) 2005-11-10
AU1069900A (en) 2000-07-03
AR019499A1 (es) 2002-02-20
PE20001244A1 (es) 2000-11-07
US6699847B2 (en) 2004-03-02
CA2355102C (en) 2006-07-11

Similar Documents

Publication Publication Date Title
HN1997000072A (es) Procedimiento para la preparacion de sildenafil
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
DK1133474T3 (da) 3-Substituerede 4-arylquinolin-2-onderivater som kaliumkanal-modulatorer
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DE69725745D1 (de) Injizierbare zusammensetzungen
NO20003600D0 (no) Kaliumkanal inhibitorer
SE9802729D0 (sv) Novel Compounds
BR9908391A (pt) Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
ES2189992T3 (es) Reduccion del crecimiento del pelo.
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
PA8486601A1 (es) Formulaciones antiparasitos
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
NO20031860L (no) Kahalalid F
BR9912916B1 (pt) composição de mistura polimérica, pelìcula, e, artigo de fabricação.
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
ATE320422T1 (de) Metalloproteinase inhibitoren
TR199901386T2 (en) �midazopiridazinler.
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
NO20021309D0 (no) Preparat for IVF
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
ES2141691T1 (es) Procedimiento para la cristalizacion de (s)-n,n'-bis(2-hidroxi-1-(hidroximetil)etil)-5-((2-hidroxi-1-oxopropil)amino)-2,4,6-triyodo-1,3-bencenodicarboxamida en un alcohol (c5-c6) lineal o ramificado o sus mezclas.